FDA Drug Recalls

Recalls / Class II

Class IID-0602-2018

Product

Valacyclovir Tablets USP 1 gram, 30-count bottle, Rx Only, Manufactured for Camber Pharmaceuticals, Inc. Piscataway, NJ 08854 By: Hetero Hetero Labs Limit Unit V Pollypally Jadcherla Mahaboob Nagar - 509 301 India NDC # 31722-705-30

Brand name
Valacyclovir
Generic name
Valacyclovir
Active ingredient
Valacyclovir Hydrochloride
Route
Oral
NDCs
31722-704, 31722-705
FDA application
ANDA203047
Affected lot / code info
Lot # VLC17027 Exp 07-2019

Why it was recalled

Temperature Abuse: Valganciclovir Tablets USP 450 mg and Valacyclovir Tablets USP 1 gram were exposed to higher temperature at airport or cargo and in the same consignment of Famciclovir complaint batch (D-0415-2018).

Recalling firm

Firm
Hetero Labs Limited Unit V
Manufacturer
Camber Pharmaceuticals, Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
Unit V (SEZ Unit I in APIIC SEZ), Surv. No. 439-441, 458, Polepally Vill., Jadcherla Mandal, Mahaboob Nagar, N/A, India

Distribution

Quantity
48132 60-count bottles
Distribution pattern
NJ and then distributed Nationwide in the USA

Timeline

Recall initiated
2018-02-13
FDA classified
2018-03-16
Posted by FDA
2018-03-21
Terminated
2021-02-18
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0602-2018. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: Valacyclovir · FDA Drug Recalls